Sol-Gel (SLGL): Price to Sales

Symbol and logo of brand Sol-Gel Technologies Ltd (SLGL)

The Sol-Gel Technologies (SLGL) strategy is based on the implementation of unique microencapsulation to combat rosacea. Tracking the company's current P/S on GURU.Markets, we note that the 102.90 level serves as a critical mark. Staff stability is ensured by generous stock options for chemical technologists. The business is currently focusing on collecting royalties from mature products and developing new topical agents.

Sol-Gel Technologies - SLGL Market Cap to Revenue (period 07/04/2022 - 11/13/2026)

Analytical breakdowns for Sol-Gel (SLGL)

- price and consensus price forecast:
Market Chart sol-gel.com|SLGL - Price Target Chart
- stock exchange capitalization data:
Market Value Sol-Gel|SLGL - Total Company Value
- shareholders' equity book value data:
Net Assets per Single Share Sol-Gel Technologies|SLGL - Company Net Assets|Market Value to Equity Ratio sol-gel.com|SLGL - Company Total Assets
- issuer credit burden and liquidity indicators:
Debt to Capital Ratio Sol-Gel Technologies|SLGL - Long-Term Debt to Capital|Current Liabilities to Capital Sol-Gel Technologies, Ltd.|SLGL - Company Debts|Debt to Book Capitalization Ratio Sol-Gel|SLGL - Company Long-Term Liabilities|Company Short-Term Loans and Borrowings Sol-Gel Technologies|Intermediate Liquidity Ratio sol-gel.com
- financial results and valuation multiples details:
SLGL - Net Profit|Expected Net Profit Sol-Gel Technologies|SLGL - P/E Multiple|Projected Price to Earnings Sol-Gel Technologies Ltd|SLGL - PEG Multiple|Business Value to Operating Income Before Depreciation Sol-Gel|SLGL - Profit before payment of interest, taxes and amortization|Earnings per share for the last 12 months Sol-Gel Technologies|SLGL - Earnings per share for the last twelve months|Earnings per share growth in annualized terms for the last twelve months sol-gel.com|SLGL - Earnings per share growth in current year|Net earnings per share growth forecast for next year Sol-Gel Technologies
- sales revenue and business income indicators:
SLGL - Company Revenue|Company Expected Sales Volume sol-gel.com|SLGL - P/S Multiple|Projected Price to Revenue Sol-Gel
Fundamental company analysis:sol-gel.com SLGL
Manufactured product of Sol-Gel Technologies Ltd.

Sol-Gel Technologies (SLGL) monetizes patented salt technologies for the treatment of skin diseases in the US market. The company's P/S ratio reflects the relationship between current market capitalization and annual revenue. This metric allows for an assessment of asset management efficiency and business recovery rates, excluding subjective evaluations. Analyzing this ratio helps investors timely recognize the risk of asset overheating or a potential undervaluation of fundamental value.

Who Sol-Gel Technologies competes with

Price-to-Revenue Coefficient krystalbio.com|Price-to-Revenue Ratio Apogee Therapeutics, Inc. APGE|Arcutis (ARQT) - Price to Sales|VCEL - Price-to-Revenue Ratio|ORKA: Price-to-Revenue Ratio|SMTI (sanaramedtech.com) - Market Cap to Revenue|Price-to-Revenue Multiple DBV Technologies DBVT|SLSN (Solesence Beauty) - P/S Multiple|DERM - Price-to-Revenue Multiple|P/S Multiple FBRX|EMPG - Price to Sales|Price-to-Revenue Ratio AXIL Brands AXIL|medicuspharma.com - Price-to-Revenue Ratio|VRCA: Market Cap to Revenue|Market Capitalization-to-Revenue Ratio HOTH (Hoth Therapeutics, Inc.)|BFRI (biofrontera-us.com) - Market Cap to Revenue|VYNE: Market Cap to Sales Volume|SNOA (Sonoma Pharmaceuticals Inc.) - P/S Multiple|Price to Sales Quoin Pharma QNRX|P/S Multiple AZTR|Market Cap to Revenue Dermata Therapeutics Inc DRMA|P/S Multiple ELAB (Elevai Skincare)|Market Capitalization-to-Revenue Ratio RVNC